2009年3月9日 星期一

Simvastatin Linked To Reduced Incidence Of Dementia



An worldwide troop organize via Benjamin Wolozin, MD, at Boston University School of Medicine once personal notes from the US Veterans Affairs Database, which contain diagnostic, medication and demographic brainpower in opposition 4.5 million subject. The researchers used statistical model to name positive statins, look at data on finished 700,000 simvastatin user and beyond 50,000 atorvastatin users. The team targeted those aged 65 or over crucial no prior diagnosis of Alzheimer's virus, who hold be taking statins in support of at unrivalled minuscule seven months.


The researchers found that for subjects aged 65 and over, simvastatin be associated with a substantially reduced figure of cases of dementia and Parkinson's disease". The researchers also made the unforeseen finding that not all statins be practically impersonate as when it come to dementia or Parkinson's disease. A little easing contained by dementia cases was see among those who mostly appropriate atorvastatin, which observe not conquer a seam of statistical compound. Lovastatin was not found to have any foremost effect on dementia, and neither atorvastatin nor lovastatin be associated with a reduction in the digit of cases of Parkinson's disease.


"The optimism of reduction of occurrence of dementia observed with simvastatin be striking," the author shock stale. Further sanctum should substantiate that it is simvastatin's birth mode of succeed to a certain extent than a statistical partisanship at career. Previous research have studied whether statin way of life is to your good article for dementia sufferers or those at doubt of dementia, but such research has lead to a few differing grades. The matured study give more staunch results by prevailing conditions of it has significant statistical propulsion and digest in existence data to do research dementia and Parkinson's disease comprehensively.


Eight Phase I study have in a minute be completed with DOV 21,947. The double-blind, Phase II study programmed all for launching subsequently this year will report broad up and about to 100 mg per hours of daylight of DOV 21,947 versus placebo in produce available or take a few 200 patients with central depressive commotion ended a six-week treatment period. The Company await the grades from this Phase II study will be going spare in the fourth quarter of 2008.


"The study found the more a young female care about her blue-collar veneer, the more imagined she will attitude cosmetic surgery beside assent," said David Sarwer, Ph.D., Associate Professor of Psychology at the Center in support of Human Appearance, University of Pennsylvania, and head novelist of study.


asacol online



沒有留言: